From: Predictive model for 5-year mortality after breast cancer surgery in Taiwan residents
Variable | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
OR (95% CI) | P value | OR (95% CI) | P value | |
Age | 1.02 (1.02–1.03) | 0.001 | 1.03 (1.03–1.04) | 0.001 |
Charlson comorbidity index | 1.18 (1.14–1.22) | 0.001 | 1.15 (1.11–1.20) | 0.001 |
Circulatory system comorbidity | ||||
Yes vs. no | 1.08 (0.77–1.53) | 0.641 | 0.89 (0.62–1.28) | 0.543 |
Genitourinary system comorbidity | ||||
Yes vs. no | 0.76 (0.50–1.15) | 0.198 | 0.84 (0.54–1.30) | 0.441 |
Breast cancer surgery type | ||||
MRM vs. BCS | 1.04 (0.97–1.12) | 0.247 | 1.03 (0.95–1.12) | 0.448 |
MRM + TRAM vs. BCS | 1.02 (0.98–1.06) | 0.475 | 1.01 (0.98–1.04) | 0.790 |
Chemotherapy | ||||
Yes vs. no | 1.57 (1.30–1.90) | 0.001 | 1.92 (1.55–2.38) | 0.001 |
Radiotherapy | ||||
Yes vs. no | 1.46 (1.11–1.92) | 0.006 | 1.52 (1.13–2.05) | 0.006 |
Hormone therapy | ||||
Yes vs. no | 0.74 (0.59–0.92) | 0.006 | 0.79 (0.68–0.90) | 0.006 |
Hospital level | ||||
Medical center vs. district hospital | 0.98 (0.94–1.02) | 0.276 | 0.98 (0.95–1.02) | 0.161 |
Regional hospital vs. district hospital | 0.94 (0.86–1.03) | 0.149 | 0.95 (0.89–1.02) | 0.092 |
Surgery volume of hospital | 0.94 (0.92–0.96) | 0.001 | 0.95 (0.92–0.98) | 0.004 |
Surgery volume of surgeon | 0.93 (0.91–0.96) | <0.001 | 0.93 (0.90–0.97) | <0.001 |